论文部分内容阅读
西方国家的临床试验表明:高强度聚焦超声(HIFU)能够杀死癌细胞,但很少有HIFU被应用于临床。在澳大利亚、日本和法国,临床应用也只局限于前列腺癌。然而,从1998～2002年,中国应用HIFU技术已经成功地治疗了10000多个癌症患者。这些患者有骨癌、肝癌、胰腺癌、皮肤癌等。目前,至少有三家厂商生产HIFU设备(有些已出口)。2002年8月,西雅图时报以“中国在HIFU方面的医疗优势”为题,介绍了第二届国际医疗超声研讨会(ISTU2),从中得出的结论是:“不要害怕气泡”。
Clinical trials in Western countries show that high-intensity focused ultrasound (HIFU) can kill cancer cells, but few HIFU are used clinically. In Australia, Japan and France, clinical application is limited to prostate cancer. However, from 1998 to 2002, China has successfully treated more than 10,000 cancer patients using HIFU technology. These patients have bone cancer, liver cancer, pancreatic cancer, skin cancer and so on. Currently, at least three manufacturers produce HIFU devices (some are exported). In August 2002, the Seattle Times introduced the 2nd International Medical Ultrasound Symposium (ISTU2) titled “China’s Medical Advantages in HIFU”. The conclusion was: “Do not be afraid of bubbles.”